Federal courts have issued conflicting rulings on gender-affirming care in recent weeks, creating uncertainty for patients, providers, and insurers.
Appeals court backs DOJ in telehealth records case
A federal appeals court last week sided with the Justice Department in its attempt to obtain patient records from QueerDoc, a telehealth company that provides gender-affirming care. The 2-1 decision marked a rare victory for federal law enforcement after similar subpoenas were blocked by other courts.
The panel determined the request was not overreach, despite objections from most judges in previous cases. Legal experts believe the decision may lead to an en banc review, where the full court would reconsider the matter.
If the trend continues, rules could vary by region, leaving providers and patients subject to different standards depending on their state. Federal agencies typically try to prevent such inconsistencies, but courts have not aligned with that goal.
Court strikes down Trump-era rule excluding gender-affirming care
A district court invalidated a Trump administration rule this month that attempted to remove gender-affirming care from the Affordable Care Act’s “essential health benefits.” The judges ruled the administration did not follow proper procedure when proposing the change.
Related: New Data Could Sway Prostate Focal Therapy Debate
While only a few states explicitly include transgender health care in their essential benefits, most cover it under broader categories like prescription drugs. The decision removes one barrier for patients seeking insurance reimbursement but does not guarantee coverage.
Legal uncertainty leaves providers in limbo
The conflicting rulings have left telehealth companies and hospitals unsure how to respond to federal requests for patient records. Some providers have complied with subpoenas, while others have challenged them in court, arguing the demands appear politically driven.
The Justice Department has not clarified why it is targeting records related to gender-affirming care. The timing, coinciding with state bans on such treatments, has drawn scrutiny.
For now, the legal disputes show no signs of resolution. The Supreme Court may eventually intervene, but until then, the uncertainty remains.
Patients and doctors continue to handle these challenges.